PFSRSONJ
Police & Firemen's Retirement System of New Jersey Portfolio holdings
AUM
$10.8B
This Quarter Return
+3.92%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$10.3B
AUM Growth
–
Cap. Flow
+$10.3B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
3,011
New
3,011
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$521M |
| 2 |
iShares MSCI India ETF
INDA
|
$494M |
| 3 |
NVIDIA
NVDA
|
$457M |
| 4 |
Microsoft
MSFT
|
$456M |
| 5 |
Amazon
AMZN
|
$300M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 26.94% |
| 2 | Financials | 13.56% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Healthcare | 9.35% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Lyell Immunopharma
LYEL
$211M
| $22.4K | ﹤0.01% |
+35,001
| New | +$22.4K |
|
2927
Lexicon Pharmaceuticals
LXRX
$414M
| $21.9K | ﹤0.01% |
+29,715
| New | +$21.9K |
|
2928
Virgin Galactic
SPCE
$176M
| $21.7K | ﹤0.01% |
+3,691
| New | +$21.7K |
|
2929
Virco
VIRC
$134M
| $21.5K | ﹤0.01% |
+2,100
| New | +$21.5K |
|
2930
Renovaro
RENB
$55.1M
| $21.5K | ﹤0.01% |
+25,695
| New | +$21.5K |
|
2931
Editas Medicine
EDIT
$232M
| $21.3K | ﹤0.01% |
+16,786
| New | +$21.3K |
|
2932
Cassava Sciences
SAVA
$113M
| $21.1K | ﹤0.01% |
+8,950
| New | +$21.1K |
|
|
CTNM
2933
Contineum Therapeutics
CTNM
$308M
| $20.5K | ﹤0.01% |
+1,396
| New | +$20.5K |
|
2934
scPharmaceuticals
SCPH
$297M
| $20.2K | ﹤0.01% |
+5,708
| New | +$20.2K |
|
|
RGLS
2935
DELISTED
Regulus Therapeutics
RGLS
| $20.1K | ﹤0.01% |
+12,696
| New | +$20.1K |
|
2936
Adverum Biotechnologies
ADVM
$64.6M
| $19.5K | ﹤0.01% |
+4,182
| New | +$19.5K |
|
2937
Contango ORE
CTGO
$277M
| $19.5K | ﹤0.01% |
+1,944
| New | +$19.5K |
|
2938
Tenaya Therapeutics
TNYA
$178M
| $19.4K | ﹤0.01% |
+13,577
| New | +$19.4K |
|
2939
Stem
STEM
$122M
| $19.4K | ﹤0.01% |
+32,110
| New | +$19.4K |
|
|
IGMS
2940
DELISTED
IGM Biosciences
IGMS
| $19.3K | ﹤0.01% |
+3,156
| New | +$19.3K |
|
2941
B. Riley Financial
RILY
$168M
| $19K | ﹤0.01% |
+4,132
| New | +$19K |
|
2942
Orchestra BioMed
OBIO
$147M
| $18.7K | ﹤0.01% |
+4,671
| New | +$18.7K |
|
2943
Alto Neuroscience
ANRO
$102M
| $18.3K | ﹤0.01% |
+4,320
| New | +$18.3K |
|
2944
Solid Biosciences
SLDB
$428M
| $18.1K | ﹤0.01% |
+4,528
| New | +$18.1K |
|
|
TPIC
2945
DELISTED
TPI Composites
TPIC
| $17.5K | ﹤0.01% |
+9,270
| New | +$17.5K |
|
2946
Harvard Bioscience
HBIO
$21.6M
| $17.3K | ﹤0.01% |
+8,194
| New | +$17.3K |
|
2947
OptimizeRx
OPRX
$336M
| $17.2K | ﹤0.01% |
+3,532
| New | +$17.2K |
|
2948
Generation Bio
GBIO
$40.4M
| $16.7K | ﹤0.01% |
+15,793
| New | +$16.7K |
|
2949
Applied Therapeutics
APLT
$72.7M
| $16.5K | ﹤0.01% |
+19,329
| New | +$16.5K |
|
2950
Black Diamond Therapeutics
BDTX
$162M
| $16K | ﹤0.01% |
+7,468
| New | +$16K |
|